Phase 1/2A Study of Glutathione Pegylated Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (Bm) from Solid Tumors or Recurrent High Grade Gliomas (Hgg)Dieta Brandsma, Philippe Aftimos, Bojana Milojkovic Kerklaan et al.|Annals of Oncology|2014Cited by 33
Abstract 5687: Development of glutathione pegylated liposomal doxorubicin (2B3-101) for the treatment of brain cancerPieter J. Gaillard, Olaf van Tellingen, Dieta Brandsma et al.|Cancer Research|2012Cited by 15
Abstract P6-16-04: Phase 1/2a study of glutathione PEGylated liposomal doxorubicin (2B3-101) in breast cancer patients with brain metastasesPhilippe Aftimos, Dieta Brandsma, Jan H.M. Schellens et al.|Cancer Research|2015Cited by 6